Home  Media Press releases 2004
|
|
|
| 25 February 2004 | 2004-02-25T00:00:00.0000000-00:00 |
|
ASTRAZENECA ISSUES 2003 ANNUAL REPORT
AstraZeneca today published its Annual Report and Form 20-F for 2003 and its 2003 Annual Review. These documents are available on the company’s website www.astrazeneca.com, (click on Investor Relations - Annual Reports).
|
AstraZeneca's 2003 Summary Corporate Responsibility Report, is also published today and is available on www.astrazeneca.com, (click on Responsibility – CR Reports).
AstraZeneca is a major international healthcare business engaged in the research, development, manufacture and marketing of prescription pharmaceuticals and the supply of healthcare services. It is one of the top five pharmaceutical companies in the world with healthcare sales of over $18.8 billion and leading positions in sales of gastrointestinal, oncology, cardiovascular, neuroscience and respiratory products. AstraZeneca is listed in the Dow Jones Sustainability Index (Global and European) as well as the FTSE4Good Index.
Media Enquiries:
Edel McCaffrey, Tel: +44 (0) 207 304 5034
Steve Brown, Tel: +44 (0) 207 304 5033
Investor Relations:
Mina Blair Robinson, Tel: +44 (0) 207 304 5084
Jonathan Hunt, Tel: +44 (0) 207 304 5087
|
|
|